NCT06600503

Brief Summary

The goal of this clinical trial is to investigate the effect of a mobile application intervention on postoperative lung rehabilitation. The main purposes of this study are:

  1. 1.To understand the effectiveness of the pulmonary rehabilitation mobile application in improving lung function.
  2. 2.To assess the feasibility of the pulmonary rehabilitation mobile application in post-surgery rehabilitation care.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.1 years

First QC Date

September 10, 2024

Last Update Submit

September 17, 2024

Conditions

Keywords

pulmonary rehabilitationmobile applicationTelerehabilitationLung cancer

Outcome Measures

Primary Outcomes (5)

  • Exercise capacity-oxygen consumption

    Cardiorespiratory fitness is evaluated by a cardiopulmonary exercise test using a cycle ergometer. Participants will be encouraged to perform a cycle ergometer stress test to assess their cardiopulmonary function. During the test, the workload will gradually increase by 10 watts per minute until the participant reaches peak exercise capacity. Throughout the exercise test, participants will be carefully monitored for echocardiography and heart rate, and will wear a mask to analyze ventilatory outcomes using a computed gas analysis system. Peak oxygen consumption (VO2 peak) will be measured during the exercise test, and values for the difference and change in percent predicted (peak oxygen uptake \[mL/kg/min\], VO2 peak difference \[mL/kg/min\], VO2 peak change \[%\], and \[% predicted\]) will be obtained from gas analysis. The predicted values will be referenced from the system based on race, age, height, biological sex, and weight.

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

  • Exercise capacity-workload

    Cardiorespiratory fitness is evaluated by a cardiopulmonary exercise test using a cycle ergometer. Participants will be encouraged to perform a cycle ergometer stress test to assess their cardiopulmonary function. During the test, the workload will gradually increase by 10 watts per minute until the participant reaches peak exercise capacity. Throughout the exercise test, participants will be carefully monitored for echocardiography and heart rate, and will wear a mask to analyze ventilatory outcomes using a computed gas analysis system. The workload achieved during exercise test will be recored by peak work rate (watts), and peak work rate (%pred.) The predicted workload will be referenced from the system based on race, age, height, biological sex, and weight.

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

  • Exercise capacity-ventilatory efficiency

    Cardiorespiratory fitness is evaluated by a cardiopulmonary exercise test using a cycle ergometer. Participants will be encouraged to perform a cycle ergometer stress test to assess their cardiopulmonary function. During the test, the workload will gradually increase by 10 watts per minute until the participant reaches peak exercise capacity. Throughout the exercise test, participants will be carefully monitored for echocardiography and heart rate, and will wear a mask to analyze ventilatory outcomes using a computed gas analysis system. The gas analysis of oxygen exchange efficiency includes maximal ventilation (L/min), maximal ventilation (% predicted), ventilatory equivalents slope, VE/VCO2 slope, ventilatory equivalents, and VE/VCO2 (% predicted).

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

  • Exercise capacity-Anaerobic threshold

    Cardiorespiratory fitness is evaluated by a cardiopulmonary exercise test using a cycle ergometer. Participants will be encouraged to perform a cycle ergometer stress test to assess their cardiopulmonary function. During the test, the workload will gradually increase by 10 watts per minute until the participant reaches peak exercise capacity. Throughout the exercise test, participants will be carefully monitored for echocardiography and heart rate, and will wear a mask to analyze ventilatory outcomes using a computed gas analysis system. Anaerobic threshold (AT) (mL/kg/min) is defined as a nonlinear increase in CO2 production, which will be analyze during gas analysis in an incremental exercise test.

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

  • Pulmoanry function

    The pulmonary function test, assessed by spirometry, is performed to evaluate lung volumes over time and ventilatory capacity. Participants will be guided by experienced therapists to take a maximal inspiration, then exhale with maximal effort for as long and as fast as possible. Measurements include forced vital capacity (FVC \[L, % predicted\]), forced expiratory volume in one second (FEV1 \[L, % predicted\]), and the ratio of the two volumes (FEV1/FVC \[% predicted\]). The predicted values will be referenced from large population studies of healthy adults, matched by race, age, height, biological sex, and weight.

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

Secondary Outcomes (5)

  • Global respiratory muscle strength

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

  • Six Minute Walk Test, 6MWT

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

  • Postoperative pulmonary complications

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

  • Quality of life - EORTC QLQ-C30

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

  • Qulaity of life-WHOQOL-BREF

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

Other Outcomes (3)

  • Demographic data

    Baseline, post-surgery assessment at week 5, follow-up assessment at week 8

  • Adherence

    Post-surgery assessment will be conducted at week 5, followed by a follow-up assessment at week 8.

  • Compliance

    Post-surgery assessment will be conducted at week 5, followed by a follow-up assessment at week 8.

Study Arms (2)

application inttervention group

EXPERIMENTAL

The experimental group will receive standard postoperative care, including chest rehabilitation, a mobile application for remote self-training every day after surgery, and an interactive healthcare web platform for health education.

Behavioral: RehabLung mobile applicationOther: Healthcare interactive Web Platform

Usual care group

ACTIVE COMPARATOR

The usual care group will receive standard postoperative care, including chest rehabilitation and an interactive healthcare web platform for health education

Behavioral: Lung cancer postoperative standard careOther: Healthcare interactive Web Platform

Interventions

Participants in the intervention group will receive in-person pulmonary rehabilitation during their surgical admission and access to a mobile pulmonary rehabilitation application for self-training. This program begins one month before surgery and continues for seven weeks after surgery. The application is designed to encourage participants to engage in pulmonary rehabilitation exercises from preoperative preparation through postoperative care. It offers guided chest breathing exercises, using visual and movement instructions created and remotely prescribed by a physical therapist. Participants will receive daily breathing exercise prescriptions throughout the study period.

Also known as: The application group, RehabLung App
application inttervention group

Participants in the usual care group will receive in-person pulmonary rehabilitation during surgical admission, pre-operative healthcare, and guidance on breathing exercises to practice before surgery. They will also receive post-operative breathing exercise prescriptions to follow at home.

Also known as: usual care, Standard chest rehabilitation
Usual care group

The healthcare interactive Web Platform provides patients with surgical information through animations. This includes an introduction to lung surgery, preparation procedures, answers to common patient questions, post-surgery wound care, and a brief guide to pulmonary rehabilitation.

Usual care groupapplication inttervention group

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age over 20 years
  • primary diagnosis of lung cancer at any stage and type
  • referral to lung cancer resection by thoracotomy or videothoracoscopy
  • ability to understand and consent to the trial procedures
  • conscious and cognition intact

You may not qualify if:

  • included adjuvant treatments (chemotherapy or radiotherapy)
  • previous history of thoracic surgery
  • neurological and/or musculoskeletal comorbidities
  • visual or hearing impairment
  • acute respiratory illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Hsin-lun Yang, MS.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 10, 2024

First Posted

September 19, 2024

Study Start

October 1, 2024

Primary Completion

October 31, 2025

Study Completion

December 31, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

IPD sharing plan will be decided after summarized data being published.